glycyrrhizin
known
exert
antivir
antiinflammatori
effect
effect
approv
parenter
glycyrrhizin
prepar
stronger
neominophafen
c
investig
highli
pathogen
influenza
viru
replic
apoptosi
proinflammatori
respons
lung
epitheli
cell
therapeut
glycyrrhizin
concentr
substanti
inhibit
express
proinflammatori
molecul
interleukin
effect
glycyrrhizin
concentr
mgml
interf
replic
apoptosi
lesser
extent
effect
glycyrrhizin
concentr
mgml
higher
glycyrrhizin
also
diminish
monocyt
migrat
toward
supernat
cell
mechan
glycyrrhizin
interfer
replic
proinflammatori
gene
express
includ
inhibit
format
reactiv
oxygen
speci
turn
reduc
activ
nfkb
jnk
redoxsensit
signal
event
known
relev
influenza
viru
replic
therefor
glycyrrhizin
may
complement
arsen
potenti
drug
treatment
diseas
highli
pathogen
influenza
virus
consid
potenti
influenza
pandem
progenitor
least
first
wave
pandem
suffici
amount
adequ
vaccin
avail
therefor
antivir
therapi
influenza
virus
includ
highli
pathogen
viru
strain
remain
great
import
first
line
defens
viru
neuraminidas
inhibitor
oseltamivir
zanamivir
well
adamantan
amantadin
rimantadin
interfer
influenza
protein
licens
treament
influenza
howev
use
drug
class
limit
emerg
resist
viru
strain
season
influenza
strain
major
virus
great
proport
virus
human
consid
amantadineand
rimantadineresist
moreov
drastic
increas
oseltamivirresist
virus
report
influenza
season
northern
hemispher
preliminari
data
unit
state
predict
rise
season
possibl
result
circul
strain
oseltamivir
resist
viru
strain
appear
gener
less
sensit
antivir
treatment
season
influenza
viru
strain
treatmentresist
strain
emerg
moreov
parenter
agent
treatment
serious
ill
patient
miss
glycyrrhizin
triterpen
saponin
constitu
licoric
root
found
interfer
replic
andor
cytopathogen
effect
cpe
induct
mani
virus
includ
respiratori
virus
respiratori
syncyti
viru
sar
coronaviru
hiv
influenza
virus
moreov
antiinflammatori
immunomodulatori
properti
attribut
glycyrrhizin
sever
human
diseas
associ
hypercytokinaemia
cytokin
storm
delay
antivir
plu
immunomodul
treatment
reduc
mortal
mice
therefor
antiinflammatori
immunomodulatori
effect
exert
glycyrrhizin
may
benefici
treatment
also
glycyrrhizin
known
antioxid
antioxid
alreadi
shown
interfer
influenza
viru
replic
virusinduc
proinflammatori
respons
stronger
neominophagen
c
snmc
glycyrrhizin
prepar
avail
tablet
parenter
formul
approv
japan
treatment
chronic
hepat
diseas
market
japan
china
korea
taiwan
indonesia
india
mongolia
investig
influenc
snmc
replic
cytokin
express
cellular
oxid
stress
critic
cellular
signal
event
human
pneumocyt
cell
line
glycyrrhizin
stronger
neo
minophagen
c
obtain
minophagen
pharmaceut
co
ltd
tokyo
japan
influenza
strain
receiv
influenza
centr
nation
institut
medic
research
london
uk
influenza
strain
athailand
obtain
prof
pilaipan
puthavathana
mahidol
univers
bangkok
thailand
viru
stock
prepar
infect
vero
cell
african
green
monkey
kidney
atcc
manassa
va
aliquot
store
viru
titr
determin
tissu
cultur
infecti
dose
tcid
ml
confluent
vero
cell
microtit
plate
cell
human
lung
carcinoma
atcc
obtain
lgc
standard
gmbh
wesel
germani
grown
minim
essenti
medium
mem
supplement
fb
iuml
penicillin
mgml
streptomycin
human
monocyt
isol
buffi
coat
healthi
donor
obtain
institut
transfus
medicin
immun
haematolog
german
red
cross
blood
donor
center
johann
wolfgang
goetheunivers
frankfurt
main
centrifug
ficol
biocol
hypaqu
densiti
gradient
biochrom
ag
berlin
germani
mononuclear
cell
collect
interfac
wash
pb
monocyt
isol
use
magnet
label
microbead
miltenyi
biotec
gmbh
bergisch
gladbach
germani
follow
manufactur
instruct
monocyt
cultiv
imdm
supplement
pool
human
serum
iuml
penicillin
mgml
streptomycin
cellular
viabil
assess
confluent
cell
layer
celltitergloh
luminesc
cell
viabil
assay
promega
gmbh
mannheim
germani
accord
manufactur
protocol
cell
viabil
express
percentag
nontreat
control
determin
intracellular
np
localis
fix
hour
pi
min
icecold
aceton
methanol
mallinckrodt
baker
bv
devent
netherland
stain
mous
monoclon
antibodi
h
incub
pb
direct
influenza
viru
nucleoprotein
np
millipor
molsheim
franc
alexa
fluor
goat
antimous
igg
h
l
invitrogen
eugen
oregon
usa
use
h
incub
pb
secondari
antibodi
nuclei
stain
use
dapi
sigmaaldrich
chemi
gmbh
munich
germani
fluoresc
visualis
use
olympu
ix
fluoresc
microscop
olympu
planegg
germani
flow
cytometr
analysi
antibodi
use
cytopathogen
effect
cpe
reduct
assay
perform
describ
confluent
cell
monolay
grown
microtitr
plate
infect
influenza
strain
indic
multipl
infect
moi
one
hour
adsorpt
period
cell
wash
remov
nondetach
viru
virusinduc
cpe
record
h
post
infect
pi
unless
otherwis
state
cell
continu
treat
glycyrrhizin
start
h
preincub
period
timeofaddit
experi
glycyrrhizin
ad
exclus
h
preincub
period
exclus
h
adsorpt
period
exclus
washout
input
viru
total
rna
isol
cell
cultur
use
tri
reagent
sigmaaldrich
munich
germani
real
time
pcr
perform
use
describ
method
follow
primer
use
sens
acg
tat
gac
tac
ccg
cag
tat
tca
g
antisens
aga
cca
gci
acc
atg
att
gc
probe
aca
gtg
gcg
agt
tcc
cta
gcatamra
fraction
cell
fraction
dna
content
cell
subpopul
indic
cytotox
cell
consid
dead
usual
apoptot
cell
cell
fix
ethanol
two
hour
cellular
dna
stain
use
propidium
iodid
mgml
analys
flow
cytometri
facscalibur
bd
bioscienc
heidelberg
germani
caspas
activ
measur
use
caspaseglo
assay
promega
mannheim
germani
follow
manufactur
instruct
cell
cultur
supernat
collect
frozen
cytokineschemokin
quantifi
specif
elisa
duo
set
r
system
gmbh
wiesbaden
germani
follow
manufactur
instruct
nfkb
activ
investig
moi
infect
cell
quantif
nfkb
subunit
rel
nuclear
extract
use
transam
tm
transcript
factor
dnabind
elisa
activ
motif
rixensart
belgium
nuclear
extract
prepar
use
nuclear
extract
kit
activ
motif
carlsbad
ca
usa
follow
manufactur
instruct
cell
cultur
supernat
investig
chemotact
activ
measur
activ
induc
monocyt
migrat
membran
insert
plate
pore
size
mm
bd
bioscienc
heidelberg
germani
monocyt
ml
imdm
pool
human
serum
ad
cell
cultur
insert
upper
chamber
cell
cultur
supernat
ml
ad
lower
chamber
well
h
incub
period
cell
fix
paraformaldehyd
permeabilis
pb
contain
tritron
nuclei
stain
dapi
upper
side
membran
wipe
wet
swab
remov
cell
lower
side
membran
rins
pb
number
cell
lower
side
membran
quantifi
count
cell
three
randomli
chosen
section
mm
use
olympu
ix
fluoresc
microscop
olympu
planegg
germani
cell
lyse
triton
xsampl
buffer
separ
sdspage
nuclear
extract
prepar
use
nuclear
extract
kit
activ
motif
carlsbad
ca
usa
follow
manufactur
instruct
protein
detect
use
specif
antibodi
bactin
sigmaaldrich
chemi
gmbh
munich
germani
jnk
phosphoryl
jnk
phosphoryl
purchas
new
england
biolab
gmbh
frankfurt
main
germani
visualis
enhanc
chemiluminesc
use
commerci
avail
kit
amersham
freiburg
germani
reactiv
oxygen
speci
ro
detect
use
imageit
live
green
reactiv
oxygen
speci
kit
molecular
probe
distribut
invitrogen
karlsruh
germani
two
group
compar
ttest
group
compar
anova
subsequ
studentnewmankeul
test
cell
line
deriv
human
pulmonari
adenocarcinoma
establish
model
type
ii
pneumocyt
commonli
use
investig
effect
influenza
virus
cell
type
see
eg
otherwis
state
glycyrrhizin
continu
present
cell
cultur
media
start
h
preinfect
period
glycyrrhizin
mgml
maximum
test
concentr
affect
cell
viabil
data
shown
clearli
decreas
cpe
format
cell
infect
influenza
strain
moi
figur
similar
result
obtain
cell
infect
strain
suppl
figur
stain
cell
influenza
nucleoprotein
h
infect
strain
indic
glycyrrhizin
mgml
significantli
reduc
number
influenza
nucleoprotein
posit
cell
figur
examin
influenc
glycyrrhizin
viru
progeni
cell
infect
influenza
strain
moi
moi
infecti
viru
titr
determin
h
post
infect
figur
glycyrrhizin
concentr
mgml
affect
replic
moder
effect
exert
glycyrrhizin
mg
ml
pronounc
effect
glycyrrhizin
mgml
moi
reduct
moi
reduct
next
influenc
glycyrrhizin
replic
confirm
detect
viral
rna
use
quantit
pcr
glycyrrhizin
concentr
mgml
significantli
reduc
figur
suppl
figur
cell
moi
h
post
infect
timeofaddit
experi
reveal
maxim
effect
achiev
glycyrrhizin
continu
present
start
h
preincub
period
figur
addit
glycyrrhizin
post
infect
show
reduc
antivir
effect
preincub
alon
glycyrrhizin
addit
adsorpt
period
significantli
affect
replic
investig
cytokin
express
five
proinflammatori
gene
chosen
correl
sever
influenza
diseas
also
known
interferoncinduc
protein
interleukin
interleukin
also
known
also
known
monocyt
chemoattract
protein
also
known
rant
cell
infect
athailand
moi
glycyrrhizin
treatment
perform
mgml
cytokin
express
detect
h
post
infect
elisa
glycyrrhizin
affect
cytokin
express
noninfect
cell
data
shown
inhibit
express
cytokin
investig
cell
dosedepend
manner
figur
figur
effect
pronounc
lower
moi
notabl
express
cytokin
except
significantli
inhibit
treatment
glycyrrhizin
mgml
figur
although
glycyrrhizin
concentr
effect
replic
cell
figur
figur
cytokin
express
influenza
virusinfect
respiratori
cell
caus
recruit
peripher
blood
monocyt
lung
patient
differenti
macrophag
thought
contribut
influenza
viru
pathogen
chemotaxi
assay
influenc
glycyrrhizin
investig
migrat
monocyt
toward
supernat
moi
infect
cell
mm
filter
monocyt
migrat
toward
supernat
cell
strongli
increas
rel
migrat
toward
supernat
noninfect
cell
treatment
infect
cell
glycyrrhizin
mgml
clearli
suppress
chemoattract
activ
supernat
figur
influenza
virus
includ
shown
induc
caspasedepend
apoptosi
airway
cell
apoptosi
correl
viru
pathogen
glycyrrhizin
concentr
mgml
affect
caspas
activ
noninfect
cell
figur
glycyrrhizin
concentr
mgml
inhibit
moi
induc
activ
initi
caspas
well
effector
caspas
cell
determin
h
post
infect
figur
lower
glycyrrhizin
concentr
affect
apoptosi
detect
cell
phase
result
similar
find
figur
substanc
inhibit
caspas
activ
includ
caspas
inhibitor
caus
nuclear
retent
rnp
complex
accord
glycyrrhizin
also
interf
nuclear
export
rnp
moi
figur
similar
result
obtain
moi
cell
figur
influenc
glycyrrhizin
activ
nuclear
factor
kb
nfkb
cellular
reactiv
oxygen
speci
ro
format
activ
nfkb
jnk
associ
influenza
viru
replic
virusinduc
proinflammatori
gene
express
glycyrrhizin
influenc
nfkb
activ
noninfect
cell
test
concentr
data
shown
glycyrrhizin
inhibit
nfkb
activ
cell
figur
moreov
glycyrrhizin
inhibit
phosphoryl
mapk
jnk
figur
addit
role
influenza
viru
replic
virusinduc
cytokinechemokin
express
nfkb
jnk
constitu
redoxsensit
signal
pathway
antioxid
alreadi
found
interfer
influenza
virusinduc
signal
nfkb
jnk
influenza
viru
replic
influenza
virusinduc
proinflammatori
gene
express
sinc
glycyrrhizin
known
exert
antioxid
effect
specul
glycyrrhizin
may
interfer
ro
format
inde
glycyrrhizin
exert
clear
antioxid
effect
moi
infect
cell
figur
caus
signific
reduct
ro
format
alreadi
concentr
mgml
figur
show
glycyrrhizin
inhibit
replic
highli
pathogen
influenza
viru
apoptosi
express
proinflammatori
cytokin
lungderiv
cell
intraven
administr
achiev
plasma
concentr
glycyrrhizin
describ
mgml
therefor
glycyrrhizin
concentr
found
interfer
replic
proinflammatori
gene
express
present
report
rang
therapeut
plasma
level
notabl
although
higher
glycyrrhizin
concentr
need
interfer
sar
coronaviru
replic
replic
benefici
result
report
glycyrrhizin
snmc
treat
sar
patient
comparison
sar
patient
receiv
glycyrrhizin
notabl
investig
differ
glycyrrhizin
deriv
sar
coronaviru
led
identif
compound
enhanc
antivir
activ
therefor
glycyrrhizin
might
also
serv
lead
structur
develop
novel
antiinfluenza
drug
experiment
result
suggest
glycyrrhizin
might
abl
affect
season
influenza
viru
diseas
antivir
immunomodulatori
effect
mice
prevent
lethal
infect
glycyrrhizin
although
influenc
viru
replic
detect
mechan
suggest
induct
interferonc
tcell
glycyrrhizin
moreov
glycyrrhizin
shown
influenc
season
influenza
viru
replic
interact
cell
membran
howev
effect
observ
concentr
mgml
glycyrrhizin
ad
viru
adsorpt
period
sinc
glycyrrhizin
addit
adsorpt
period
influenc
replic
experi
appear
like
membran
effect
contribut
effect
detect
lower
concentr
result
rather
suggest
glycyrrhizin
interfer
oxid
stress
influenza
viru
includ
infect
induc
ro
format
antioxid
found
inhibit
influenza
viru
replic
influenza
virusinduc
proinflammatori
gene
express
glycyrrhizin
known
exert
antioxid
effect
glycyrrhizin
interf
activ
nfkb
jnk
repres
redoxsensit
signal
event
involv
influenza
viru
replic
influenza
virusinduc
cellular
cytokinechemokin
product
glycyrrhizin
mgml
significantli
reduc
activ
nfkb
addit
glycyrrhizin
concentr
low
mgml
effect
interf
ro
format
phosphoryl
redoxsensit
mapk
jnk
model
activ
appear
critic
redox
signal
sinc
inhibit
shown
mimick
effect
antioxid
nacetylcystein
nac
interestingli
contrast
glycyrrhizin
nac
fail
inhibit
replic
cytokinechemokin
express
therapeut
relev
concentr
glycyrrhizin
diminish
cellular
cytokin
chemokin
product
concentr
mgml
interfer
replic
although
redoxsensit
signal
pathway
describ
involv
process
therefor
proinflammatori
gene
express
appear
sensit
inhibit
ro
format
replic
inde
influenza
virus
shown
induc
cellular
pathway
replicationdepend
independ
event
previou
report
could
show
similar
glycyrrhizin
concentr
like
investig
interf
proinflammatori
gene
express
replic
human
monocytederiv
macrophag
addit
immunomodulatori
treatment
regimen
influenc
replic
reduc
mortal
mice
therefor
glycyrrhizin
repres
potenti
addit
treatment
option
interf
replic
express
proinflammatori
cytokin
lung
cell
interfer
immun
respons
may
also
result
loss
control
viru
replic
cytotox
immun
cell
includ
natur
killer
cell
cytotox
tlymphocyt
global
immunosuppress
like
corticosteroid
fail
protect
lethal
influenza
viru
infect
moreov
antivir
drug
may
interfer
cytotox
cell
control
viru
replic
demonstr
ribavirin
shown
hamper
nk
cell
cytolyt
activ
context
glycyrrhizin
alreadi
shown
affect
natur
killer
cell
activ
concentr
use
conclus
show
report
therapeut
concentr
glycyrrhizin
use
clinic
approv
parenter
prepar
snmc
interfer
highli
pathogen
influenza
viru
replic
proinflammatori
gene
express
least
part
interfer
ro
format
turn
reduc
activ
jnk
nfkb
lung
cell
sinc
use
clinic
formul
snmc
effect
ingredi
like
glycin
cystein
exclud
vaccin
antivir
agent
fail
meet
global
need
least
begin
sever
influenza
viru
pandem
antiinflammatori
immunomodulatori
agent
consid
import
candid
constitu
antiinfluenza
treatment
strategi
may
save
live
influenza
pandem
situat
therefor
glycyrrhizin
may
complement
arsen
potenti
drug
treatment
diseas
